Leading Beyond The Lab
autor: ARTO Talent
The Evolution of Medical Affairs in Global Pharma
O tomto podcastu
The Leading Beyond The Lab Podcast is hosted by Lawrence Rose, one of the Directors at ARTO, a talent solutions agency specialising in leadership roles within the Life Sciences sector globally.
This podcast provides insightful discussions with industry experts, leaders and innovators, shaping the future in drug development and clinical devices. We talk with biotechnology and/or pharmaceutical executives, and find out from them their stories, personal career development and analyse their opinion on how to become successful in this space. We talk on a range of topics including soft skills, oncology, leadership, micromanagement, investment, cardiology, AI, dementia, addiction, hematology, dermatology, and much more.
This podcast applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
397181
Hosted on Acast. See acast.com/privacy for more information.
Epizody
Nejnovějších 20 z 37 epizod
- The Evolution of Medical Affairs in Global Pharma · 36 min · Epizoda 37What does it really take to transform Medical Affairs from a scientific support function into one of the biggest strategic drivers in pharmaceutical innovation? In this episode…
- How One AI Platform Is Cutting Years Off Drug Discovery - Yann Gaston-Mathé · 51 min · Epizoda 3695% of our viewers aren't subscribed. If you're watching and not yet subscribed, please subscribe to the channel so you don't miss future episodes. What does it take to improve…
- The Next Generation of Autoimmune Therapies? Inside SciRhom’s IRhom2 Platform · 57 min · Epizoda 3595% of our viewers aren’t subscribed. If you’re watching and not yet subscribed, please subscribe to the channel so you don’t miss future episodes. Can targeting IRhom2 unlock a…
- We’re Developing The Next Generation Of Parkinson’s Therapies, And Here's How - Brenig Therapeutics · 1 h 4 min · Epizoda 3495% of our viewers aren’t subscribed. If you’re watching and not yet subscribed, please subscribe to the channel so you don’t miss future episodes. This week on Leading Beyond…
- AI Is About to Simulate Human Biology - Bioptimus · 56 min · Epizoda 3395% of our viewers aren’t subscribed. If you’re watching and not yet subscribed, please subscribe to the channel so you don’t miss future episodes. Can AI become a universal…
- I Built A Billion-Dollar Company, Lost It All... Then Built Another 5 - Robert Wessman · 1 h 23 min · Epizoda 32What does it take to build not just one billion-dollar company, but seven and start again after losing it all? In this episode, Robert Wessman shares the mindset, discipline and…
- AI Discovering Medicines Humans Could Never Find: James Field - LabGenius Therapeutics · 47 min · Epizoda 31AI is beginning to uncover medicines that humans alone could never design. This week on another episode of Leading Beyond the Lab, we host James Field, CEO and Founder of…
- Will the Drug Work? Engineering a New Future for Oncology - BioCortex · 58 min · Epizoda 3090% of our listeners don't realise they aren't subscribed - please check! What if we could predict whether a drug will work, before it ever reaches a patient? This week, in…
- A Single Injection set to Eliminate Cancer? CEO of Candel Therapeutics - Paul Peter Tak · 1 h 1 min · Epizoda 29What if a single injection could teach the immune system to eliminate cancer, and keep it away? This week, in another episode of Leading Beyond the Lab, Lawrence Rose sits down…
- Is AI About to Collapse the Cost of Healthcare — Or Is This Another Tech Bubble? | Edward Kliphuis · 41 min · Epizoda 28If AI is collapsing the cost of healthcare — are we on the brink of a historic breakthrough… or another bubble? This week on Leading Beyond the Lab, we sit down with @Edward…
- Parkinson’s Breakthrough Could Be Just Around the Corner | BlueRock Therapeutics · 29 min · Epizoda 27From science fiction to clinical reality. What happens when cell therapy moves from promise to proof in patients who have run out of options? This week on Leading Beyond the…
- How Smart Capital Is Shaping the Future of Biotech - Jonathan Tobin · 44 min · Epizoda 2697% of our viewers don't realise they aren't followed, please double check, thank you! What does it really take to back and build world-class biotech companies from idea to FDA…
- Nikhil Thatte On Investing In Best In Class Biotech and Medtech Companies · 45 min · Epizoda 25This episode is a masterclass in how world-class life sciences investors think about risk, conviction, and real patient impact. This week on Leading Beyond The Lab, Lawrence…
- How NodThera’s NLRP3 Marks A New Era for Obesity Treatment · 42 min · Epizoda 24Cardio-metabolic diseases are the world’s biggest killer. But what if the next generation of treatments could change everything? This week on Leading Beyond The Lab, Lawrence…
- How To Get Investment from Joey Mason | 25 Years In Life Sciences VC · 52 min · Epizoda 2325 years of life sciences venture experience in one episode. This week on Leading Beyond The Lab, @Lawrence Rose sat down with @Joey Mason, a venture investor with 25 years of…
- How Syncona built a $1Billion Dollar NAV Portfolio - Roel Bulthuis · 45 min · Epizoda 22🤔 What does it really take to build a biotech that survives the clinical gauntlet and scales into a global business? 🎬 This week on Leading Beyond The Lab, Lawrence Rose sat…
- CEO of LEO Pharma Reveals Their IPO Strategy: Christophe Bourdon · 35 min · Epizoda 21A once-in-a-century transformation, and the leader driving it. This week, in one of our biggest episode of Leading Beyond the Lab yet, we sit down with Christophe Bourdon, CEO…
- Building a High-Impact Biotech Investment Engine - Clare Terlouw · 40 min · Epizoda 20What does it take to shape a high-impact biotech investment portfolio - and do it under a medical charity mandate? This week we sit down with Clare Terlouw, Head of LifeArc…
- Is Nuclear Medicine Becoming Next Big Breakthrough in Oncology Treatment? Danielle Meyrick · 35 min · Epizoda 19If you're not paying attention to nuclear medicine, Danielle Meyrick will change that in under five minutes. This week, we sit down with Dr. Danielle Meyrick, Director and…
- Normunity's Breakthrough Cancer Drug the World Hasn't Seen Before · 40 min · Epizoda 18Two of the most influential minds in immuno-oncology walk into a biotech… and build something that could change everything. Dr. Rachel Humphrey (CEO) and Dr. Melinda Merchant…







